Fathom Therapeutics
PrivateAI and quantum chemistry-driven drug discovery company (formerly Atommap). The Microcosmos engine simulates protein dynamics at atomic resolution roughly 10,000x faster than conventional methods, designing small-molecule medicines for historically undruggable targets.
Founders Huafeng Xu, Jesus Izaguirre
CEO Huafeng Xu
Company
Founded
2023
Headquarters
New York, United States
Financials
Total Funding
$54M
Funding History
2 rounds Series A Apr 27, 2026
$47M Seed Nov 16, 2023
$7M Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.